- Home
- RVTY vs EXAS Comparison
RVTY vs EXAS Comparison
Compare RVTY & EXAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVTY
- EXAS
- Stock Information
- Founded
- RVTY 1937
- EXAS 1995
- Country
- RVTY United States
- EXAS United States
- Employees
- RVTY N/A
- EXAS N/A
- Industry
- RVTY Biotechnology: Laboratory Analytical Instruments
- EXAS Medical Specialities
- Sector
- RVTY Industrials
- EXAS Health Care
- Exchange
- RVTY Nasdaq
- EXAS Nasdaq
- Market Cap
- RVTY 15.1B
- EXAS 12.3B
- IPO Year
- RVTY N/A
- EXAS N/A
- Fundamental
- Price
- RVTY $111.33
- EXAS $52.70
- Analyst Decision
- RVTY Buy
- EXAS Strong Buy
- Analyst Count
- RVTY 16
- EXAS 17
- Target Price
- RVTY $129.40
- EXAS $73.07
- AVG Volume (30 Days)
- RVTY 1.0M
- EXAS 3.4M
- Earning Date
- RVTY 11-04-2024
- EXAS 11-05-2024
- Dividend Yield
- RVTY 0.25%
- EXAS N/A
- EPS Growth
- RVTY N/A
- EXAS N/A
- EPS
- RVTY 2.06
- EXAS N/A
- Revenue
- RVTY $2,721,555,000.00
- EXAS $2,692,328,000.00
- Revenue This Year
- RVTY $2.34
- EXAS $12.41
- Revenue Next Year
- RVTY $5.58
- EXAS $11.64
- P/E Ratio
- RVTY $53.64
- EXAS N/A
- Revenue Growth
- RVTY N/A
- EXAS 11.91
- 52 Week Low
- RVTY $86.30
- EXAS $40.62
- 52 Week High
- RVTY $129.50
- EXAS $79.62
- Technical
- Relative Strength Index (RSI)
- RVTY 33.99
- EXAS 35.13
- Support Level
- RVTY $107.17
- EXAS $48.72
- Resistance Level
- RVTY $120.85
- EXAS $54.55
- Average True Range (ATR)
- RVTY 4.20
- EXAS 3.06
- MACD
- RVTY -1.29
- EXAS -0.72
- Stochastic Oscillator
- RVTY 18.61
- EXAS 18.86
About RVTY Revvity Inc.
Revvity provides instruments, tests, services, and software solutions to the pharmaceutical, biomedical, chemical, environmental, and general industrial markets. The company operates in two segments. First, its diagnostics segment includes immunodiagnostics, reproductive health, and applied genomics. Second, its discovery and analytical solutions is composed of life science, industrial, environmental, and food applications. Revvity offers products and services ranging from genetic screening and environmental analytical tools to informatics and enterprise software.
About EXAS Exact Sciences Corporation
Exact Sciences Corporation, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test, a noninvasive stool-based DNA test, is a pre-cancer screening test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, or MRD, colorectal cancer screening, and multicancer screening.